Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals

Mak, Willem A; Koeleman, Johannes G M; Ong, David S Y

doi:https://doi.org/10.1016/j.jcv.2022.105158

Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals

DSpace/Manakin Repository

Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals

Mak, Willem A; Koeleman, Johannes G M; Ong, David S Y

(2022) Journal of Clinical Virology, volume 150-151

(Letter)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Antibodies, Viral, COVID-19, Enzyme-Linked Immunospot Assay, Humans, SARS-CoV-2, T-Lymphocytes, Letter, Research Support, Non-U.S. Gov't

DOI: https://doi.org/10.1016/j.jcv.2022.105158

ISSN: 1386-6532

Publisher: Elsevier

(Peer reviewed)